Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Nature Cell Biology|May 7, 2021
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapyGaopeng Li, Ilona Kryczek, Jutaek Nam, et al.Proceedings of the National Academy of Sciences of the United States of America|February 19, 2021
The male germline-specific protein MAPS is indispensable for pachynema progression and fertilityMiao Li, Jiahuan Zheng, Gaopeng Li, et al.Peerj|November 29, 2023
Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathwayChang Liu, Yuqi Jia, Xinan Zhao, et al.Nature Communications|May 29, 2026
Non-decameric NLRP3 reveals a TGN/MTOC-distal pathway of inflammasome activationMaría Mateo-Tórtola, Inga V Hochheiser, Gaopeng Li, et al.Cell Research|March 23, 2016
CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistanceGaopeng Li, Xiaoli Wu, Wenchang Qian, et al.Nature Immunology|March 26, 2021
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunityJiajia Zhou, Ilona Kryczek, Shasha Li, et al.Cancer Gene Therapy|October 25, 2019
ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinomaXiuli Mu, Xi Wang, Yan Wei, et al.Hepatology (Baltimore, Md.)|April 12, 2018
Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant miceFeifei Zhang, Zhimin Hu, Gaopeng Li, et al.The Journal of Biological Chemistry|June 23, 2017
Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cellsSheng Tan, Keshuo Ding, Qing-Yun Chong, et al.Cancer Discovery|February 25, 2021
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and DegradationWan Du, Fang Hua, Xiong Li, et al.Pageof 9